Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial.

Details

Language :

English

ISSN :

01406736

Volume :

370

Issue :

9581

Database :

Academic Search Index

Journal :

Lancet

Publication Type :

Academic Journal

Accession number :

105959707

Full Text :

https://doi.org/10.1016/s0140-6736(07)61049-6